You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Al18F-NOTA-octreotide

Showing 1 - 25 of 8,160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Leuven (Al18F-NOTA-octreotide, PET/CT, PET/MR)

Completed
  • Neuroendocrine Tumors
  • Al18F-NOTA-octreotide
  • +2 more
  • Leuven, Belgium
    Universitaire Ziekenhuizen Leuven
Feb 16, 2022

Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

Recruiting
  • Neuroendocrine Tumor
  • Beijing, Chao Yang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Malignancy Trial in Beijing (Al18F-NOTA-FAPI)

Recruiting
  • Malignancy
  • Beijing, Chao Yang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023

Breast Cancer Trial in Beijing (Al18F-NOTA-FAPI-04 PET/CT scan)

Recruiting
  • Breast Cancer
  • Al18F-NOTA-FAPI-04 PET/CT scan
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 10, 2022

Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

Recruiting
  • Aldosterone-Producing Adenoma
  • [18F]AlF-NOTA-pentixather PET/CT
  • Chengdu, Sichuan, China
    Sichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023

18F-FAPI PET/CT Examination, Renal Puncture Biopsy Trial ([18F]AlF-NOTA-FAPI-04 PET/CT examination, Renal puncture biopsy)

Not yet recruiting
  • 18F-FAPI PET/CT Examination
  • Renal Puncture Biopsy
  • [18F]AlF-NOTA-FAPI-04 PET/CT examination
  • Renal puncture biopsy
  • (no location specified)
Mar 1, 2023

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

Recruiting
  • Malignancy
  • Al18F-PSMA-BCH PET/CT
  • Beijing, Chaoyang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023

Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)

Recruiting
  • Amyloid
  • Amyloid Cardiomyopathy
  • 18F-florbetaben PET/CT
  • Pisa, Italy
    Fondazione Toscana Gabriele Monasterio
Sep 16, 2023

Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis Trial ([18F]florbetaben)

Not yet recruiting
  • Cardiac Amyloidosis
  • +2 more
  • (no location specified)
Apr 22, 2022

Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

Recruiting
  • Bladder Cancer
  • [68Ga]-NOTA-SGC8
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 14, 2023

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Solid Tumor, Positron-Emission Tomography(PET) Trial in Suzhou ([68Ga]Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • [68Ga]Ga-NOTA-SNA002
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 3, 2022

Breast Cancer Trial in Nanjing (18F-Alfatide ? PET/CT)

Terminated
  • Breast Cancer
  • 18F-Alfatide Ⅱ PET/CT
  • Nanjing, Jiangsu, China
    Jinling Hospital
Sep 25, 2019

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Healthy Volunteers Trial in Birmingham (CSB-111)

Recruiting
  • Healthy Volunteers
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 25, 2022

Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

Recruiting
  • Hepatocellular Carcinoma
  • [68Ga]Ga-NOTA-RG2 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Insulinoma Trial in Fuzhou (68Ga-NOTA-exendin-4)

Recruiting
  • Insulinoma
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 29, 2022

Hepatic Carcinoma, Hepatic Metastasis Trial in Pamplona (Octreotide, Placebo)

Recruiting
  • Hepatic Carcinoma
  • Hepatic Metastasis
  • Pamplona, Spain
    Clinica Universidad de Navarra
Oct 10, 2023

Seroma Following Procedure Trial in Ibadan (Octreotide Injection, Sterile water)

Completed
  • Seroma Following Procedure
  • Octreotide Injection
  • Sterile water
  • Ibadan, Oyo, Nigeria
    University College Hospital
Jan 13, 2023

Lymphatic Diseases, Chylothorax Trial in København Ø (Octreotide Injection, Saline infusion)

Completed
  • Lymphatic Diseases
  • Chylothorax
  • Octreotide Injection
  • Saline infusion
  • København Ø, Denmark
    Rigshospitalet
Jan 4, 2023

Primary Dysmenorrhea Trial (Effleurage Abdominal Massage)

Not yet recruiting
  • Primary Dysmenorrhea
  • Effleurage Abdominal Massage
  • (no location specified)
Sep 26, 2023

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NOTA-AE105, PET/CT)

Completed
  • Neuroendocrine Tumors
  • One injection of 68Ga-NOTA-AE105
  • PET/CT
  • Copenhagen, Denmark
    Department of Clinical Physiology, Nuclear Medicine and PET, Rig
Jun 28, 2022